LISATA THERAPEUTICS, INC.
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Company / filing name
- LISATA THERAPEUTICS, INC. [1]
- Headquarters location
- New York City [2]
- Founded
- 2006 [2]
- Legal form
- Delaware corporation [2]
- Official website
- www.caladrius.com ↗ [2]
- ISIN (reported securities)
- US1280583022 [2]
- CIK
- 320017 [1]
- Country in background record
- United States [2]
- Symbols / exchanges
- LSTA (Nasdaq) [1]
Company positioning and business
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022. [3]
In 2019, the FDA granted their product, certepetide (also known as iRGD and CEND-1), orphan drug status in pancreatic cancer, followed by a Fast track (FDA) status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. [3]
Background text: Wikipedia contributors, Lisata Therapeutics. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
Listed securities: LSTA (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [1]
History and key events
Founding / inception date recorded in Wikidata. [2]
Financial results and regulatory disclosures
No individual financial documents have been indexed yet. Open the source to consult company disclosures. [1]
Related entities and concepts
Frequently asked questions
When was LISATA THERAPEUTICS, INC. founded?
Founded: 2006. The linked source provides the background record. [2]
Where is the headquarters of LISATA THERAPEUTICS, INC.?
Headquarters location: New York City. The linked source provides the background record. [2]
Sources and review dates
- Company identity and profile data ↗
- Wikidata — company background record (CC0) ↗
- Wikipedia contributors — Lisata Therapeutics (CC BY-SA 4.0) ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.